Evidence map›Paper›PMID 41222666›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

The 2025 ATA guidelines for differentiated thyroid Cancer - Ten years of professional debate and measured progress.

Petra Petranović Ovčariček, Frederik Anton Verburg, Bart de Keizer, Alfredo Campennì, Murat Tuncel, Michael C Kreissl, Désirée Deandreis, Luca Giovanella

Abstract readEditorial
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Challenges and unmet needs of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Petra Petranović OvčaričekDepartment of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, 10000, Croatia. p.petranovic@gmail.com.ORCID http://orcid.org/0000-0003-1946-2128
Frederik Anton VerburgDepartment of Radiology and Nuclear Medicine, Erasmus Medical Centre, Postbus 2040, Rotterdam, 3000 CA, The Netherlands.
Bart de KeizerDepartment of Nuclear Medicine and Radiology, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands.
Alfredo CampennìDepartment of Biomedical and Dental Sciences and Morpho-Functional Imaging, Unit of Nuclear Medicine, University of Messina, Messina, 98100, Italy.
Murat TuncelDepartment of Nuclear Medicine, Hacettepe University, Ankara, 06230, Turkey.
Michael C KreisslDivision of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, Otto-Von-Guericke University, Magdeburg, 39120, Germany.
Désirée DeandreisInstitute Gustave Roussy, Villejuif, 94800, France.
Luca GiovanellaDepartment of Nuclear Medicine, Gruppo Ospedaliero Moncucco SA, Clinica Moncucco, Via Soldino 10, Lugano, 6900, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.